Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Active combination drug for treating hemiplegia and/or paraplegia

A drug and quick-acting technology, applied in the direction of drug combination, pharmaceutical formula, plant raw materials, etc., can solve the problems of inability to take care of yourself, inconvenient use, slow effect, etc., and achieve the effect of short course of treatment, good effect, and quick effect.

Inactive Publication Date: 2018-06-01
王显明
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The patient is bedridden all the year round and cannot take care of himself. The patient is in great pain and brings great burden to the family and society.
[0006] At present, hemiplegia and paraplegia are one of the difficult diseases that human medicine is conquering. Although there are some auxiliary treatment measures, such as carotid arterial pressurization drug injection therapy, there are defects such as long treatment course, slow effect, high price and inconvenient use.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Active combination drug for treating hemiplegia and/or paraplegia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0056] A quick-acting combined drug for treating hemiplegia and / or paraplegia, the combined drug consists of composition 1, composition 2, composition 3 and composition 4, wherein:

[0057] The composition 1 is an injection, and the injection includes vitamin B 1 and vitamin B 12 , the vitamin B 1 With the mass volume ratio of injection 2g:100mL, the vitamin B 12 The mass volume ratio with the injection is 20mg / 100mL;

[0058] The composition 2 is an injection, and the injection includes glucose, coenzyme A, ATP, creatinine and vitamin C, wherein the mass volume ratio of the glucose to the injection is 25g / 250mL, and the coenzyme A and the injection The ratio is 150U / 250mL, the mass volume ratio of the inosine to the injection is 0.1g / 250mL, and the mass volume ratio of the vitamin C to the injection is 5g / 250mL;

[0059] The composition 3 is an injection, and the injection includes glucose and Xuesaitong, wherein the mass volume ratio of the glucose to the injection is 3g...

Embodiment 2

[0062] A quick-acting combined drug for treating hemiplegia and / or paraplegia, the combined drug consists of composition 1, composition 2, composition 3 and composition 4, wherein:

[0063] The composition 1 is an injection, and the injection includes vitamin B 1 and vitamin B 12 , the vitamin B 1 With the mass volume ratio of injection 3.333g:100mL, the vitamin B 12 The mass volume ratio with the injection is 16.65mg / 100mL;

[0064] The composition 2 is an injection, and the injection includes glucose, coenzyme A, ATP, creatinine and vitamin C, wherein the mass volume ratio of the glucose to the injection is 25g / 250mL, and the coenzyme A and the injection The ratio is 100U / 250mL, the mass volume ratio of the inosine to the injection is 0.2g / 250mL, and the mass volume ratio of the vitamin C to the injection is 3g / 250mL;

[0065] The composition 3 is an injection, and the injection includes glucose and Xuesaitong, wherein the mass volume ratio of the glucose to the injectio...

Embodiment 3

[0068] A quick-acting combined drug for treating hemiplegia and / or paraplegia, the combined drug consists of composition 1, composition 2, composition 3 and composition 4, wherein:

[0069] The composition 1 is an injection, and the injection includes vitamin B 1 and vitamin B 12 , the vitamin B 1 With the mass volume ratio of injection 4g:100mL, the vitamin B 12 The mass volume ratio with the injection is 15mg / 100mL;

[0070] The composition 2 is an injection, and the injection includes glucose, coenzyme A, ATP, creatinine and vitamin C, wherein the mass volume ratio of the glucose to the injection is 30g / 100mL, and the coenzyme A and the injection The ratio is 50U / 250mL, the mass volume ratio of the inosine to the injection is 0.5g / 250mL, and the mass volume ratio of the vitamin C to the injection is 1g / 250mL;

[0071] The composition 3 is an injection, and the injection includes glucose and Xuesaitong, wherein the mass volume ratio of the glucose to the injection is 7g / ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
volumeaaaaaaaaaa
Login to View More

Abstract

The invention relates to an active combination drug for treating hemiplegia and / or paraplegia. The combination drug is characterized by comprising a composition 1, a composition 2, a composition 3 anda composition 4, wherein the composition 1 comprises vitamin B1 and vitamin B12; the composition 2 comprises glucose, coenzyme A, ATP, creatinine and vitamin C; the composition 3 comprises glucose and a xuesaitong injection; and the composition 4 comprises multi-vitamin, troxerutin, acyclovir and amoxicillin. The combination drug can dredge main and collateral channels and smooth qi and blood, ensures that main and collateral channels blocked by affections, such as hemiplegia and / or paraplegia, are smoothed, does not need surgery, and has the advantages of quick effect, short course of treatment and good effect in terms of the treatment of hemiplegia and paraplegia.

Description

technical field [0001] The invention relates to the field of pharmaceutical compositions, in particular to a quick-acting combination medicine for treating hemiplegia and / or paraplegia. Background technique [0002] Hemiplegia is a popular term for stroke. Because most of the stroke patients show that half of the body is ineffective, it is often called hemiplegia vividly. Traditional Chinese medicine calls it stroke or hemiplegia. Western medicine calls it cerebrovascular disease or stroke. [0003] Due to cerebrovascular disease, brain tissue is damaged, and intracranial nerve cells are damaged, and the motor nerve cells in the motor nucleus of the cranial nerve and the anterior horn of the gray matter of the spinal cord push the control and cause the corresponding part of the body to be paralyzed. Hemiplegia is clinically manifested as crooked mouth and eyes, movement disorders of one upper and lower extremity, facial muscles and lower tongue muscles, and slurred speech. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/258A61P9/10A61P25/00A61K31/51A61K31/714A61K31/7004A61K31/7076A61K31/375A61K31/7048A61K31/522A61K31/43A61K31/4415A61K31/07A61K31/59A61K31/355A61K31/4168
CPCA61K31/07A61K31/355A61K31/375A61K31/4168A61K31/43A61K31/4415A61K31/51A61K31/522A61K31/59A61K31/7004A61K31/7048A61K31/7076A61K31/714A61K36/258A61K2300/00
Inventor 王显明
Owner 王显明
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com